Seborrheic Dermatitis Recruiting Phase 2 Trials for Ketoconazole (DB01026)

Also known as: Seborrhea / Seborrhoeic dermatitis / Dermatitis, Seborrheic / Seborrheic eczema / Dermatitis seborrheic / Dermatitis seborrhoeic / Eczema seborrhoeic / Seborrhoea / Seborrheic dermatitis, unspecified / Skin seborrhoeic / Seborrhoeic eczema / Seborrhoeic dermatitis, unspecified / Skin seborrheic

IndicationStatusPhase
DBCOND0036095 (Seborrheic Dermatitis)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03688971Omiganan Twice a Day (BID) in Patients With Facial Seborrheic DermatitisTreatment